Literature DB >> 29024779

Kinetic characterization of bile salt transport by human NTCP (SLC10A1).

Márton Jani1, Erzsébet Beéry1, Teresa Heslop2, Beáta Tóth1, Bhavana Jagota3, Emese Kis1, B Kevin Park3, Peter Krajcsi4, Richard J Weaver5.   

Abstract

The transport of bile acids facilitated by NTCP is an important factor in establishing bile flow. In this study, we examine the kinetics associated with human NTCP-dependent transport of two quantitatively important bile acids comprising the human bile acid pool, chenodeoxycholic acid and glycine-chenodeoxycholate, and secondary bile salt, 3-sulfo-glycolithocholate of potential toxicological significance. The study employed human NTCP overexpressing Chinese Hamster Ovary cells and results compared with taurocholate, a prototypical bile salt commonly used in transporter studies. GCDC and 3S-GLC but not CDCA were transported by NTCP. The efficient uptake of GCDC, TCA and 3S-GLC by NTCP enabled the determination of kinetics. GCDC displayed a lower KM (0.569±0.318μM) than TCA (6.44±3.83μM) and 3S-GLC (3.78±1.17μM). The apparent CLint value for GCDC was 20-fold greater (153±53μl/mg protein/min) than the apparent CLint for TCA (6.92±4.72μl/mg protein/min) and apparent CLint for 3S-GLC (8.05±1.33μl/mg protein/min). These kinetic results provide important complementary data on the substrate selectivity and specificity of NTCP to transport bile acids. NTCP transports GCDC with greater efficiency than TCA and has the same efficacy for 3S-GLC and TCA.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  3-Sulfo-glycolithocholate; Glycochenodeoxycholate; Intrinsic clearance; Kinetics; NTCP; SLC10A1

Mesh:

Substances:

Year:  2017        PMID: 29024779     DOI: 10.1016/j.tiv.2017.10.012

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  4 in total

1.  Phase I study of PF‐04895162, a Kv7 channel opener, reveals unexpected hepatotoxicity in healthy subjects, but not rats or monkeys: clinical evidence of disrupted bile acid homeostasis.

Authors:  Michael D Aleo; Jiri Aubrecht; Paul D Bonin; Deborah A Burt; Jennifer Colangelo; Lina Luo; Shelli Schomaker; Rachel Swiss; Simon Kirby; Greg C Rigdon; Pinky Dua
Journal:  Pharmacol Res Perspect       Date:  2019-02

2.  Comprehensive Analysis of Long Non-coding RNA and mRNA Transcriptomes Related to Hypoxia Adaptation in Tibetan Sheep.

Authors:  Zengkui Lu; Chao Yuan; Jianye Li; Tingting Guo; Yaojing Yue; Chune Niu; Jianbin Liu; Bohui Yang
Journal:  Front Vet Sci       Date:  2022-01-24

Review 3.  A Recent Ten-Year Perspective: Bile Acid Metabolism and Signaling.

Authors:  Yulia Shulpekova; Elena Shirokova; Maria Zharkova; Pyotr Tkachenko; Igor Tikhonov; Alexander Stepanov; Alexandra Sinitsyna; Alexander Izotov; Tatyana Butkova; Nadezhda Shulpekova; Vladimir Nechaev; Igor Damulin; Alexey Okhlobystin; Vladimir Ivashkin
Journal:  Molecules       Date:  2022-03-18       Impact factor: 4.411

4.  Sodium+/taurocholate cotransporting polypeptide as target therapy for liver fibrosis.

Authors:  Ahmad Salhab; Johnny Amer; Yinying Lu; Rifaat Safadi
Journal:  Gut       Date:  2021-07-15       Impact factor: 31.793

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.